Genmab’s CEO is ecstatic over the biotech's “shining star”, bone marrow cancer drug Darzalex. He doubts he will see anything like it in his time in the company, but is working intently on finding a new cash cow.
BY LOUISE WENDT JENSEN Offentliggjort 28.02.17 kl. 16:22
Log ind for at læse artikler
Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.
A more digitalized therapy will benefit both diabetes patients and the healthcare systems’ economy, says Sanofi’s global heads of Diabetes Reseach and Integrated Care. The company wants to be at the forefront of the digital revolution, in part through a major partnership with the Google company Verily.
The world’s largest hearing device dealer, Amplifon, expresses concern over the entry into the retail market of manufacturers such as William Demant. GN Resound, on the other hand, receives praise and is expected to form even closer ties to its Italian collaborator.
The average monthly salary in the private pharmaceutical industry in Denmark is DKK 57,109. Make the jump to find out which company pays the highest wages and learn how much the rest of the industry pays as well.
The Danish hearing device giant GN Hearing has experienced Q1 growth rates unseen in years at the US subsidiary Beltone, says chief executive Anders Hedegaard. Beltone is crucial for GN’s growth in the US, estimates senior analyst.
Novo Ventures has taken the lead in a Series A financing round in a new US-based company developing medicine against the liver disease NASH – a disease that big as well as small companies have started to focus on, including Novo Nordisk.
Amerikanske Janssen har valgt at bruge en særlig kupon, som man fik fra FDA i 2012, til at fremskynde evalueringen af et nyt antistof til behandling af psoriasis. Sådanne kuponer er tidligere blevet solgt for flere milliarder kroner.
Instrukser til en ekspertkomite under FDA, som skal evaluere Pfizers biosimilære version af Amgens milliardsælgende anæmimiddel Epogen, tyder ifølge Endpoints på, at midlet inden længe vil blive godkendt i USA.